20170519 1600 IPPB RFP Bidder Queries_Debit Cards_For Release
ثبت نشده
چکیده
1 3 4 E a rn e st M o n e y D e p o si t (E M D ): A n E M D o f R s. 5 ,0 0 ,0 0 0 ( R u p e e s F iv e L a k h O n ly ) in t h e f o rm o f a d e m a n d d ra ft /p a y o rd e r d ra w n i n f a v o u r o f In d ia P o st P a y m e n ts B a n k L im it e d s h o u ld b e s u b m it te d a lo n g w it h t h e t e ch n ic a l B id . R e q u e s b a n k t o a cc e p t B a n k G u a ra n te e a s E M D . A ls o B G f o rm a t to b e p ro v id e d
منابع مشابه
Development and In Vitro Release of Isoniazid and Rifampicin-Loaded Bovine Serum Albumin Nanoparticles
BACKGROUND Bovine serum albumin nanoparticles loaded with isoniazid and rifampicin (INH-RFP-BSA-NPs) were prepared and their release characteristics were studied in vitro. MATERIAL AND METHODS The INH-RFP-BSA-NPs were prepared by a modified self-emulsion solvent diffusion method, with albumin and polylactic acid used as carriers and to form the nanoparticles structure. Transmission electron mic...
متن کاملAarc Guideline: Intermittent Positive Pressure Breathing
IPPB 2.0 DESCRIPTION/DEFINITION: The first American Association for Respiratory Care (AARC) clinical practice guideline (CPG) for Intermittent Positive Pressure Breathing (IPPB) was published in 1993. Since that time there have been additional studies, systematic overviews, and a meta-analysis that specifically addresses the eff icacy of IPPB as compared to other hyperinflation and aerosol deli...
متن کاملRelapse in a borderline-tuberculoid case of leprosy 5 years after the release from rifampicin monotherapy.
Paucibacillary cases of leprosy are now routinely being treated with two drugs, namely rifampicin (RFP) and diarnino diphenyl sulphone (DDS) . We report here a paucibacillary case of borderline-tuberculoid (BT) leprosy, who had taken a one-year course of daily RFP monotherapy, and relapsed as BT five years after the release from treatment. Mycobacterium Zeprae derived from this case was sensiti...
متن کاملIntermittent positive-pressure breathing.
Why the continued confusion over the issue of intermittent positive-pressure breathing (IPPB) as related to therapeutic benefits? Welch’s’ communication in response to the article by Loren et a12 comparing simple nebulization and IPPB in asthmatic children fails again to identify specific criteria for therapy with IPPB. Welch and Loren are both correct in identifying the ineffectiveness of ther...
متن کاملComparison of intermittent positive pressure breathing and temporary positive expiratory pressure in patients with severe chronic obstructive pulmonary disease.
BACKGROUND Results supporting the use and the effectiveness of positive expiratory, pressure devices in chronic obstructive pulmonary disease (COPD) patients are still controversial, We have tested the hypothesis that adding TPEP or IPPB to standard pharmacological therapy may provide additional clinical benefit over, pharmacological therapy only in patients with severe COPD. METHODS Fourty-f...
متن کامل